VTL Stock Overview
VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
VGI Health Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.03 |
| 52 Week Low | AU$0.02 |
| Beta | 0.56 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -90.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| VTL | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -3.2% | -0.6% |
| 1Y | n/a | 36.5% | 5.7% |
Return vs Industry: Insufficient data to determine how VTL performed against the Australian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how VTL performed against the Australian Market.
Price Volatility
| VTL volatility | |
|---|---|
| VTL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.4% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: VTL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VTL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Glenn Tong | vgiht.com |
VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies. It offers drugs and wellbeing supplements. The company also develops nE1-Heart for treatment of hyperlipidaemia; and nE1-Elite that reduce delayed onset muscle soreness, enhance muscle recovery, and provide exercise endurance and maintenance of muscle power.
VGI Health Technology Limited Fundamentals Summary
| VTL fundamental statistics | |
|---|---|
| Market cap | AU$2.76m |
| Earnings (TTM) | -AU$1.52m |
| Revenue (TTM) | AU$24.60k |
112.4x
P/S Ratio-1.8x
P/E RatioIs VTL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTL income statement (TTM) | |
|---|---|
| Revenue | AU$24.60k |
| Cost of Revenue | AU$20.74k |
| Gross Profit | AU$3.86k |
| Other Expenses | AU$1.53m |
| Earnings | -AU$1.52m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 15.69% |
| Net Profit Margin | -6,186.86% |
| Debt/Equity Ratio | -393.5% |
How did VTL perform over the long term?
See historical performance and comparison